Tier 3 · Filer Universe
ABVC BIOPHARMA, INC.
ABVC · Nasdaq · Healthcare. Identity, market observation, SEC facts, and source links remain separate and inspectable.
Price
$0.84
+0.00%
Coverage
Tier 3
Tier 3 · Filer Universe
SEC CIK
0001173313
Liquidity rank
#5789
Observed dollar volume
Tier 3 is a directory treatment. It does not imply options, analyst estimates, or complete company-facts coverage. Missing fields stay missing.
SEC XBRL facts
| Field | Value | Period end | Filing |
|---|---|---|---|
| Annual revenue | $509,589.00 | 2024-12-31 | 0001213900-26-023063 |
| Annual diluted EPS | -0.39 | 2025-12-31 | 0001213900-26-023063 |
| Quarterly revenue | $795,950.00 | 2025-09-30 | 0001213900-25-104811 |
| Quarterly diluted EPS | -0.03 | 2026-06-30 | 0001213900-26-088348 |
SEC EDGAR Frames batch generated 2026-08-24T22:57:10.491Z. Frames are calendar-aligned and may not cover every filer or fiscal period.
Filings and machine access
Latest SEC filingsSEC company browse
SEC submissions JSONDirect upstream record
Per-symbol JSONSame-origin machine contract
Context paths
HealthcareNasdaqBMY · Tier 1 peerDHR · Tier 1 peerISRG · Tier 1 peerPFE · Tier 1 peer
Provenance
Quote and corporate actionsYahoo Finance chart
FundamentalsSEC EDGAR Frames